Transações de insiders

EDGAR

ZIMMER BIOMET HOLDINGS, INC.

Transações informadas por diretores, executivos e detentores de mais de 10 % nos Formulários 3, 4 e 5 da SEC, lidas do XML de cada documento. Os códigos e sua redação são os da SEC.

O Formulário 4 deve ser entregue em até dois dias úteis após a transação; as mais recentes podem ainda não ter sido registradas.

Janela: transações datadas de 17 de nov. de 2025 em diante.

Compras no mercado aberto (código P)
0 transações, — ações
Vendas no mercado aberto (código S)
6 transações, 17.341 ações
Soma de ações × preço por ação: 1.584.583,45

Os totais somam as transações listadas; contam o que foi informado e não medem uma direção.

Exibindo 1–50 de 174

Transações de insiders, mais recentes primeiro, conforme os Formulários 3, 4 e 5 da SEC
DataDeclaranteCódigoAdquirido ou alienadoAçõesPreço por ação, conforme entregueValor (derivado)Ações detidas depoisDireta ou indiretaCaixa da Regra 10b5-1NotasFonte
1 de out. de 2026 Protocolado em 5 de out. de 2026Campbell Gary Craig Officer: President, Americas
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Adquirido (A)2.3680—2.368Direta (D) Não— Abrir documento 0002155115-26-000003 Lido do XML do documento Contestar esta linha
1 de out. de 2026 Protocolado em 5 de out. de 2026Campbell Gary Craig Officer: President, Americas
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Alienado (D)93288,42
82.407,44

Derivado: ações × preço por ação. Valor exato 82407.44.

1.436Direta (D) Não
F1
  • F1 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the Company) to satisfy tax withholding obligations on the vesting of restricted stock units (RSUs).
Abrir documento 0002155115-26-000003 Lido do XML do documento Contestar esta linha
1 de out. de 2026 Protocolado em 5 de out. de 2026Campbell Gary Craig Officer: President, Americas
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Adquirido (A)1.2180—2.654Direta (D) Não— Abrir documento 0002155115-26-000003 Lido do XML do documento Contestar esta linha
1 de out. de 2026 Protocolado em 5 de out. de 2026Campbell Gary Craig Officer: President, Americas
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Alienado (D)48088,42
42.441,6

Derivado: ações × preço por ação. Valor exato 42441.60.

2.174Direta (D) Não
F1
  • F1 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the Company) to satisfy tax withholding obligations on the vesting of restricted stock units (RSUs).
Abrir documento 0002155115-26-000003 Lido do XML do documento Contestar esta linha
1 de out. de 2026 Protocolado em 5 de out. de 2026Campbell Gary Craig Officer: President, Americas
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Valor mobiliário derivativo: Restricted Stock Units — subjacente Common Stock (2.368)
Alienado (D)2.3680—0Direta (D) Não
F2
  • F2 Each RSU represents a contingent right to receive one share of Company common stock.
Abrir documento 0002155115-26-000003 Lido do XML do documento Contestar esta linha
1 de out. de 2026 Protocolado em 5 de out. de 2026Campbell Gary Craig Officer: President, Americas
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Valor mobiliário derivativo: Restricted Stock Units — subjacente Common Stock (1.218)
Alienado (D)1.2180—2.434Direta (D) Não
F2, F3
  • F2 Each RSU represents a contingent right to receive one share of Company common stock.
  • F3 One-third of these RSUs vested on October 1, 2026. The remaining RSUs vest one-half on October 1, 2027 and one-half on October 1, 2028.
Abrir documento 0002155115-26-000003 Lido do XML do documento Contestar esta linha
30 de set. de 2026 Protocolado em 2 de out. de 2026Farrell Michael J. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (417,363) — preço de exercício 89.85
Adquirido (A)417,3630—20.073,731Direta (D) Não
F1, F2, F3, F4
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.
  • F4 Includes 49.652 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Abrir documento 0001485164-26-000010 Lido do XML do documento Contestar esta linha
30 de set. de 2026 Protocolado em 2 de out. de 2026Kurdikar Devdatt Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (173,901) — preço de exercício 89.85
Adquirido (A)173,9010—3.171,359Direta (D) Não
F1, F2, F3, F4
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
  • F4 Includes 7.276 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Abrir documento 0001910621-26-000010 Lido do XML do documento Contestar esta linha
30 de set. de 2026 Protocolado em 2 de out. de 2026HIGGINS ARTHUR J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (306,066) — preço de exercício 89.85
Adquirido (A)306,0660—38.077,496Direta (D) Não
F1, F2, F3, F4
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
  • F4 Includes 96.739 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Abrir documento 0001142083-26-000010 Lido do XML do documento Contestar esta linha
30 de set. de 2026 Protocolado em 2 de out. de 2026Hilado Maria Teresa Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (375,626) — preço de exercício 89.85
Adquirido (A)375,6260—13.392,107Direta (D) Não
F1, F2, F3, F4
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
  • F4 Includes 32.614 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Abrir documento 0001587868-26-000016 Lido do XML do documento Contestar esta linha
30 de set. de 2026 Protocolado em 2 de out. de 2026Shapiro Louis Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (153,033) — preço de exercício 89.85
Adquirido (A)153,0330—3.865,311Direta (D) Não
F1, F2, F3, F4
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
  • F4 Includes 9.178 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Abrir documento 0001999146-26-000010 Lido do XML do documento Contestar esta linha
30 de set. de 2026 Protocolado em 2 de out. de 2026Kolli Sreelakshmi Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (173,901) — preço de exercício 89.85
Adquirido (A)173,9010—7.033,757Direta (D) Não
F1, F2, F3, F4
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
  • F4 Includes 17.252 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Abrir documento 0001689392-26-000012 Lido do XML do documento Contestar esta linha
30 de set. de 2026 Protocolado em 2 de out. de 2026HAGEMANN ROBERT Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (306,066) — preço de exercício 89.85
Adquirido (A)306,0660—33.660,840Direta (D) Não
F1, F2, F3, F4
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
  • F4 Includes 85.331 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Abrir documento 0001222676-26-000012 Lido do XML do documento Contestar esta linha
11 de set. de 2026 Protocolado em 15 de set. de 2026Thornal Kevin R Officer: Grp Pres-Global Business
S

Open market or private sale of non-derivative or derivative security

Common Stock
Alienado (D)5.69192,95
528.978,45

Derivado: ações × preço por ação. Valor exato 528978.45.

0Direta (D) Não— Abrir documento 0001783992-26-000006 Lido do XML do documento Contestar esta linha
4 de set. de 2026 Protocolado em 9 de set. de 2026Phipps Chad F Officer: See remarks below.
S

Open market or private sale of non-derivative or derivative security

Common Stock
Alienado (D)3.00098,35
295.050

Derivado: ações × preço por ação. Valor exato 295050.00.

65.231Direta (D) Não
F1
  • F1 Includes 471 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through July 31, 2026.
Abrir documento 0001346672-26-000010 Lido do XML do documento Contestar esta linha
3 de ago. de 2026 Protocolado em 5 de ago. de 2026Desai Chintan Officer: President, APAC
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Restricted Stock Units — subjacente Common Stock (10.168)
Adquirido (A)10.1680—10.168Direta (D) Não
F1, F2
  • F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.
  • F2 One-third of the RSUs shall vest on each of August 3, 2027, August 3, 2028 and August 3, 2029.
Abrir documento 0002136215-26-000006 Lido do XML do documento Contestar esta linha
1 de ago. de 2026 Protocolado em 4 de ago. de 2026Thornal Kevin R Officer: Grp Pres-Global Business
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Adquirido (A)9.9570—9.957Direta (D) Não— Abrir documento 0001783992-26-000004 Lido do XML do documento Contestar esta linha
1 de ago. de 2026 Protocolado em 4 de ago. de 2026Thornal Kevin R Officer: Grp Pres-Global Business
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Alienado (D)4.26692,68
395.372,88

Derivado: ações × preço por ação. Valor exato 395372.88.

5.691Direta (D) Não
F1
  • F1 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the Company) to satisfy tax withholding obligations on the vesting of restricted stock units (RSUs).
Abrir documento 0001783992-26-000004 Lido do XML do documento Contestar esta linha
1 de ago. de 2026 Protocolado em 4 de ago. de 2026Thornal Kevin R Officer: Grp Pres-Global Business
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Valor mobiliário derivativo: Restricted Stock Units — subjacente Common Stock (9.957)
Alienado (D)9.9570—19.913Direta (D) Não
F2, F3
  • F2 Each RSU represents a contingent right to receive one share of Company common stock.
  • F3 One-third of the RSUs vested on August 1, 2026. The remaining RSUs vest one-half on each of August 1, 2027 and August 1, 2028.
Abrir documento 0001783992-26-000004 Lido do XML do documento Contestar esta linha
30 de jun. de 2026 Protocolado em 2 de jul. de 2026HIGGINS ARTHUR J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (317,369) — preço de exercício 86.65
Adquirido (A)317,3690—37.674,691Direta (D) Não
F1, F2, F3
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
Abrir documento 0001142083-26-000008 Lido do XML do documento Contestar esta linha
30 de jun. de 2026 Protocolado em 2 de jul. de 2026HAGEMANN ROBERT Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (317,369) — preço de exercício 86.65
Adquirido (A)317,3690—33.269,443Direta (D) Não
F1, F2, F3
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
Abrir documento 0001222676-26-000010 Lido do XML do documento Contestar esta linha
30 de jun. de 2026 Protocolado em 2 de jul. de 2026Kurdikar Devdatt Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (180,323) — preço de exercício 86.65
Adquirido (A)180,3230—2.990,182Direta (D) Não
F1, F2, F3
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
Abrir documento 0001910621-26-000008 Lido do XML do documento Contestar esta linha
30 de jun. de 2026 Protocolado em 2 de jul. de 2026Shapiro Louis Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (158,684) — preço de exercício 86.65
Adquirido (A)158,6840—3.703,100Direta (D) Não
F1, F2, F3
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
Abrir documento 0001999146-26-000008 Lido do XML do documento Contestar esta linha
30 de jun. de 2026 Protocolado em 2 de jul. de 2026Farrell Michael J. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (432,776) — preço de exercício 86.65
Adquirido (A)432,7760—19.606,716Direta (D) Não
F1, F2, F3
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.
Abrir documento 0001485164-26-000008 Lido do XML do documento Contestar esta linha
30 de jun. de 2026 Protocolado em 2 de jul. de 2026Kolli Sreelakshmi Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (180,323) — preço de exercício 86.65
Adquirido (A)180,3230—6.842,604Direta (D) Não
F1, F2, F3
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
Abrir documento 0001689392-26-000010 Lido do XML do documento Contestar esta linha
30 de jun. de 2026 Protocolado em 2 de jul. de 2026Hilado Maria Teresa Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (389,498) — preço de exercício 86.65
Adquirido (A)389,4980—12.983,867Direta (D) Não
F1, F2, F3
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
Abrir documento 0001587868-26-000012 Lido do XML do documento Contestar esta linha
1 de jun. de 2026 Protocolado em 3 de jun. de 2026Noor Jehanzeb Officer: See remarks below.
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Restricted Stock Units — subjacente Common Stock (1.857)
Adquirido (A)1.8570—1.857Direta (D) Não
F1, F2
  • F1 Each RSU represents a contingent right to receive one share of Company common stock.
  • F2 Vests annually over three years in increments of one-third each year, commencing June 1, 2027.
Abrir documento 0002059755-26-000006 Lido do XML do documento Contestar esta linha
29 de mai. de 2026 Protocolado em 2 de jun. de 2026Yi Sang Officer: Group President, Asia Pacific
S

Open market or private sale of non-derivative or derivative security

Common Stock
Alienado (D)4.20082,64
347.088

Derivado: ações × preço por ação. Valor exato 347088.00.

28.051Direta (D) Não— Abrir documento 0001635943-26-000013 Lido do XML do documento Contestar esta linha
29 de mai. de 2026 Protocolado em 2 de jun. de 2026Yi Sang Officer: Group President, Asia Pacific
S

Open market or private sale of non-derivative or derivative security

Common Stock
Alienado (D)80082,66
66.128

Derivado: ações × preço por ação. Valor exato 66128.00.

27.251Direta (D) Não— Abrir documento 0001635943-26-000013 Lido do XML do documento Contestar esta linha
22 de mai. de 2026 Protocolado em 27 de mai. de 2026BERNARD BETSY J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (875,35) — preço de exercício 85.68
Adquirido (A)875,350—21.581,562Direta (D) Não
F1, F2, F3, F4
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
  • F4 Includes 60.604 phantom stock units accrued on April 30, 2026, 57.375 phantom stock units accrued on January 30, 2026, 49.323 phantom stock units accrued on October 31, 2025 and 53.221 phantom stock units accrued on July 31, 2025, in each case under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Abrir documento 0001166854-26-000002 Lido do XML do documento Contestar esta linha
22 de mai. de 2026 Protocolado em 27 de mai. de 2026BERNARD BETSY J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Restricted Stock Units — subjacente Common Stock (1.517,274)
Adquirido (A)1.517,2740—24.506Direta (D) Não
F2, F5, F6
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F5 The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
  • F6 Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.
Abrir documento 0001166854-26-000002 Lido do XML do documento Contestar esta linha
22 de mai. de 2026 Protocolado em 27 de mai. de 2026Jafry Syed A. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (875,35) — preço de exercício 85.68
Adquirido (A)875,350—8.288,638Direta (D) Não
F1, F2, F3, F4
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director
  • F4 Includes 21.697 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Abrir documento 0001745891-26-000004 Lido do XML do documento Contestar esta linha
22 de mai. de 2026 Protocolado em 27 de mai. de 2026Jafry Syed A. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Restricted Stock Units — subjacente Common Stock (1.517,274)
Adquirido (A)1.517,2740—9.098Direta (D) Não
F2, F5, F6
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F5 The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
  • F6 Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.
Abrir documento 0001745891-26-000004 Lido do XML do documento Contestar esta linha
22 de mai. de 2026 Protocolado em 27 de mai. de 2026Shapiro Louis Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (875,35) — preço de exercício 85.68
Adquirido (A)875,350—3.544,416Direta (D) Não
F1, F2, F3, F4
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
  • F4 Includes 7.812 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Abrir documento 0001999146-26-000006 Lido do XML do documento Contestar esta linha
22 de mai. de 2026 Protocolado em 27 de mai. de 2026Shapiro Louis Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Restricted Stock Units — subjacente Common Stock (1.517,274)
Adquirido (A)1.517,2740—3.991,063Direta (D) Não
F2, F5, F6
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F5 The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
  • F6 Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.
Abrir documento 0001999146-26-000006 Lido do XML do documento Contestar esta linha
22 de mai. de 2026 Protocolado em 27 de mai. de 2026HIGGINS ARTHUR J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (875,35) — preço de exercício 85.68
Adquirido (A)875,350—37.357,322Direta (D) Não
F1, F2, F3, F4
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
  • F4 Includes 106.777 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Abrir documento 0001142083-26-000006 Lido do XML do documento Contestar esta linha
22 de mai. de 2026 Protocolado em 27 de mai. de 2026HIGGINS ARTHUR J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Restricted Stock Units — subjacente Common Stock (1.517,274)
Adquirido (A)1.517,2740—26.382Direta (D) Não
F2, F5, F6
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F5 The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
  • F6 Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.
Abrir documento 0001142083-26-000006 Lido do XML do documento Contestar esta linha
22 de mai. de 2026 Protocolado em 27 de mai. de 2026Hilado Maria Teresa Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (875,35) — preço de exercício 85.68
Adquirido (A)875,350—12.594,369Direta (D) Não
F1, F2, F3, F4
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
  • F4 Includes 34.300 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Abrir documento 0001587868-26-000008 Lido do XML do documento Contestar esta linha
22 de mai. de 2026 Protocolado em 27 de mai. de 2026Hilado Maria Teresa Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Restricted Stock Units — subjacente Common Stock (1.517,274)
Adquirido (A)1.517,2740—9.098Direta (D) Não
F2, F5, F6
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F5 The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as of a Director or (2) the date that is three years after the grant date.
  • F6 Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.
Abrir documento 0001587868-26-000008 Lido do XML do documento Contestar esta linha
22 de mai. de 2026 Protocolado em 27 de mai. de 2026Kurdikar Devdatt Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (875,35) — preço de exercício 85.68
Adquirido (A)875,350—2.809,859Direta (D) Não
F1, F2, F3, F4
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
  • F4 Includes 5.662 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Abrir documento 0001910621-26-000006 Lido do XML do documento Contestar esta linha
22 de mai. de 2026 Protocolado em 27 de mai. de 2026Kurdikar Devdatt Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Restricted Stock Units — subjacente Common Stock (1.517,274)
Adquirido (A)1.517,2740—2.922,072Direta (D) Não
F2, F5, F6
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F5 The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
  • F6 Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.
Abrir documento 0001910621-26-000006 Lido do XML do documento Contestar esta linha
22 de mai. de 2026 Protocolado em 27 de mai. de 2026HAGEMANN ROBERT Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (875,35) — preço de exercício 85.68
Adquirido (A)875,350—32.952,074Direta (D) Não
F1, F2, F3, F4
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
  • F4 Includes 93.883 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Abrir documento 0001222676-26-000008 Lido do XML do documento Contestar esta linha
22 de mai. de 2026 Protocolado em 27 de mai. de 2026HAGEMANN ROBERT Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Restricted Stock Units — subjacente Common Stock (1.517,274)
Adquirido (A)1.517,2740—25.927Direta (D) Não
F2, F5, F6
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F5 The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
  • F6 Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.
Abrir documento 0001222676-26-000008 Lido do XML do documento Contestar esta linha
22 de mai. de 2026 Protocolado em 27 de mai. de 2026Kolli Sreelakshmi Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (875,35) — preço de exercício 85.68
Adquirido (A)875,350—6.662,281Direta (D) Não
F1, F2, F3, F4
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
  • F4 Includes 16.937 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Abrir documento 0001689392-26-000008 Lido do XML do documento Contestar esta linha
22 de mai. de 2026 Protocolado em 27 de mai. de 2026Kolli Sreelakshmi Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Restricted Stock Units — subjacente Common Stock (1.517,274)
Adquirido (A)1.517,2740—6.875Direta (D) Não
F2, F5, F6
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F5 The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
  • F6 Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.
Abrir documento 0001689392-26-000008 Lido do XML do documento Contestar esta linha
22 de mai. de 2026 Protocolado em 27 de mai. de 2026Farrell Michael J. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Phantom Stock Units — subjacente Common Stock (875,35) — preço de exercício 85.68
Adquirido (A)875,350—19.173,94Direta (D) Não
F1, F2, F3, F4
  • F1 The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F3 Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
  • F4 Includes 53.557 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Abrir documento 0001485164-26-000006 Lido do XML do documento Contestar esta linha
22 de mai. de 2026 Protocolado em 27 de mai. de 2026Farrell Michael J. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Restricted Stock Units — subjacente Common Stock (1.517,274)
Adquirido (A)1.517,2740—13.757Direta (D) Não
F2, F5, F6
  • F2 The Conversion or Exercise Price of Derivative Security is 1-for-1.
  • F5 The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination as a Director or (2) the date that is three years after the grant date.
  • F6 Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.
Abrir documento 0001485164-26-000006 Lido do XML do documento Contestar esta linha
1 de mai. de 2026 Protocolado em 5 de mai. de 2026Stellato Paul A Officer: VP, Controller, CAO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor mobiliário derivativo: Restricted Stock Units — subjacente Common Stock (9.232)
Adquirido (A)9.2320—9.232Direta (D) Não
F1, F2
  • F1 Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock.
  • F2 Vests annually over three years in increments of one-third each year, commencing on May 1, 2027.
Abrir documento 0001714585-26-000010 Lido do XML do documento Contestar esta linha
1 de abr. de 2026 Protocolado em 3 de abr. de 2026Noor Jehanzeb Officer: See remarks below.
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Adquirido (A)6.6260—6.828Direta (D) Não
F1
  • F1 Includes 202 shares acquired under the Employee Stock Purchase Plan on December 31, 2025.
Abrir documento 0002059755-26-000004 Lido do XML do documento Contestar esta linha
1 de abr. de 2026 Protocolado em 3 de abr. de 2026Noor Jehanzeb Officer: See remarks below.
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Alienado (D)1.67790,67
152.053,59

Derivado: ações × preço por ação. Valor exato 152053.59.

5.151Direta (D) Não
F2
  • F2 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the Company) to satisfy tax withholding on the vesting of restricted stock units (RSUs).
Abrir documento 0002059755-26-000004 Lido do XML do documento Contestar esta linha

Detentores institucionais (Formulário 13F)

Trimestre encerrado em 2026-09-30: 8.793 documentos lidos, o mais recente de 16 de nov. de 2026. Trimestre anterior encerrado em 2026-06-30: 9.164 documentos lidos.

Exibindo 1–50 de 941

Detentores institucionais, maior posição primeiro, conforme entregue
GestorAções ou principalValor conforme entregueDiferença em relação ao trimestre anteriorFonte
Dodge Cox 22.732.137 SH2.019.295.730 dólaresMenor em 1.392.598 Trimestre anterior: 24.124.735Abrir documento 0001193125-26-460252 Protocolado em 13 de nov. de 2026 Contestar esta linha
BlackRock, Inc. Informado em parte sob outro gestor15.612.396 SH1.386.849.120 dólaresMenor em 2.451 Trimestre anterior: 15.614.847Abrir documento 0002012383-26-003985 Protocolado em 13 de nov. de 2026 Contestar esta linha
VANGUARD CAPITAL MANAGEMENT LLC 12.479.866 SH1.108.586.497 dólaresMenor em 155.071 Trimestre anterior: 12.634.937Abrir documento 0002100119-26-001711 Protocolado em 13 de nov. de 2026 Contestar esta linha
HARRIS ASSOCIATES L P Informado em parte sob outro gestor12.230.088 SH1.086.398.685 dólaresMenor em 507.937 Trimestre anterior: 12.738.025Abrir documento 0000813917-26-000049 Protocolado em 16 de nov. de 2026 Contestar esta linha
Capital International Investors Informado em parte sob outro gestor10.859.352 SH964.636.238 dólaresMenor em 1.324.262 Trimestre anterior: 12.183.614Abrir documento 0001562230-26-000136 Protocolado em 12 de nov. de 2026 Contestar esta linha
STATE STREET CORP Informado em parte sob outro gestor8.883.451 SH791.212.240 dólaresMaior em 6.280 Trimestre anterior: 8.877.171Abrir documento 0000093751-26-000747 Protocolado em 12 de nov. de 2026 Contestar esta linha
VANGUARD PORTFOLIO MANAGEMENT LLC 8.139.992 SH723.075.489 dólaresMenor em 301.755 Trimestre anterior: 8.441.747Abrir documento 0002100121-26-001150 Protocolado em 13 de nov. de 2026 Contestar esta linha
GEODE CAPITAL MANAGEMENT, LLC Informado em parte sob outro gestor5.387.130 SH476.711.117 dólaresMaior em 37.907 Trimestre anterior: 5.349.223Abrir documento 0001214717-26-000012 Protocolado em 6 de nov. de 2026 Contestar esta linha
Invesco Ltd. Informado em parte sob outro gestor4.128.790 SH366.760.415 dólaresMaior em 148.930 Trimestre anterior: 3.979.860Abrir documento 0000914208-26-000462 Protocolado em 12 de nov. de 2026 Contestar esta linha
PRIMECAP MANAGEMENT CO/CA/ 3.801.250 SH337.665.038 dólaresMenor em 15.430 Trimestre anterior: 3.816.680Abrir documento 0000763212-26-000037 Protocolado em 12 de nov. de 2026 Contestar esta linha
VAN ECK ASSOCIATES CORP Informado em parte sob outro gestor3.457.999 SH307.174.051 dólaresMenor em 43.655 Trimestre anterior: 3.501.654Abrir documento 0000869178-26-000119 Protocolado em 13 de nov. de 2026 Contestar esta linha
PRICE T ROWE ASSOCIATES INC /MD/ Informado em parte sob outro gestor3.298.730 SH293.027 dólaresMenor em 1.498.427 Trimestre anterior: 4.797.157Abrir documento 0000080255-26-000736 Protocolado em 16 de nov. de 2026 Contestar esta linha
MORGAN STANLEY Informado em parte sob outro gestor2.728.545 SH242.376.920 dólaresMaior em 137.042 Trimestre anterior: 2.591.503Abrir documento 0000895421-26-000309 Protocolado em 13 de nov. de 2026 Contestar esta linha
HOTCHKIS WILEY CAPITAL MANAGEMENT LLC 2.641.289 SH234.625.702 dólaresMenor em 120.140 Trimestre anterior: 2.761.429Abrir documento 0001172661-26-005357 Protocolado em 16 de nov. de 2026 Contestar esta linha
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Informado em parte sob outro gestor2.413.367 SH214.379.391 dólaresMaior em 851.228 Trimestre anterior: 1.562.139Abrir documento 0001164508-26-000060 Protocolado em 13 de nov. de 2026 Contestar esta linha
AMERICAN CENTURY COMPANIES INC Informado em parte sob outro gestor2.362.262 SH209.839.884 dólaresMenor em 382.201 Trimestre anterior: 2.744.463Abrir documento 0000748054-26-000008 Protocolado em 12 de nov. de 2026 Contestar esta linha
NORTHERN TRUST CORP Informado em parte sob outro gestor1.943.340 SH172.626.894 dólaresMenor em 21.712 Trimestre anterior: 1.965.052Abrir documento 0000073124-26-000067 Protocolado em 16 de nov. de 2026 Contestar esta linha
DIMENSIONAL FUND ADVISORS LP Informado em parte sob outro gestor1.800.316 SH159.960.055 dólaresMenor em 157.997 Trimestre anterior: 1.958.313Abrir documento 0000354204-26-001096 Protocolado em 4 de nov. de 2026 Contestar esta linha
EQUITY INVESTMENT CORP 1.776.758 SH157.829.413 dólaresMaior em 95.398 Trimestre anterior: 1.681.360Abrir documento 0001685771-26-000009 Protocolado em 4 de nov. de 2026 Contestar esta linha
BANK OF AMERICA CORP /DE/ Informado em parte sob outro gestor1.466.502 SH130.269.353 dólaresMenor em 711.222 Trimestre anterior: 2.177.724Abrir documento 0000070858-26-000589 Protocolado em 16 de nov. de 2026 Contestar esta linha
Legal General Group Plc Informado em parte sob outro gestor1.431.354 SH127.147.176 dólaresMenor em 34.175 Trimestre anterior: 1.465.529Abrir documento 0001495115-26-000075 Protocolado em 16 de nov. de 2026 Contestar esta linha
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Informado em parte sob outro gestor1.428.945 SH126.933.183 dólaresMenor em 28.608 Trimestre anterior: 1.457.553Abrir documento 0000861177-26-000005 Protocolado em 16 de nov. de 2026 Contestar esta linha
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.428.900 SH126.929.187 dólaresMaior em 51.797 Trimestre anterior: 1.377.103Abrir documento 0000884546-26-000417 Protocolado em 16 de nov. de 2026 Contestar esta linha
MANUFACTURERS LIFE INSURANCE COMPANY, THE Informado em parte sob outro gestor1.391.546 SH123.611.031 dólaresMenor em 66.713 Trimestre anterior: 1.458.259Abrir documento 0001145443-26-000111 Protocolado em 13 de nov. de 2026 Contestar esta linha
Thrivent Financial for Lutherans Informado em parte sob outro gestor1.257.306 SH111.686 dólaresMaior em 616 Trimestre anterior: 1.256.690Abrir documento 0001193125-26-449292 Protocolado em 5 de nov. de 2026 Contestar esta linha
Alyeska Investment Group, L.P. 1.170.000 SH103.931.100 dólaresNão consta nos documentos lidos do trimestre anterior Abrir documento 0001172661-26-005329 Protocolado em 16 de nov. de 2026 Contestar esta linha
UBS Group AG Informado em parte sob outro gestor1.127.503 SH100.156.091 dólaresMenor em 1.631.112 Trimestre anterior: 2.758.615Abrir documento 0001610520-26-000121 Protocolado em 10 de nov. de 2026 Contestar esta linha
Bank of New York Mellon Corp Informado em parte sob outro gestor1.083.132 SH96.214.609 dólaresMenor em 29.893 Trimestre anterior: 1.113.025Abrir documento 0001390777-26-000121 Protocolado em 5 de nov. de 2026 Contestar esta linha
VANGUARD FIDUCIARY TRUST CO 1.077.125 SH95.681.014 dólaresMenor em 9.045 Trimestre anterior: 1.086.170Abrir documento 0000933478-26-000017 Protocolado em 13 de nov. de 2026 Contestar esta linha
AMERIPRISE FINANCIAL INC Informado em parte sob outro gestor1.069.653 SH95.021.191 dólaresMaior em 28.678 Trimestre anterior: 1.040.975Abrir documento 0001193125-26-463125 Protocolado em 16 de nov. de 2026 Contestar esta linha
GOLDMAN SACHS GROUP INC Informado em parte sob outro gestor1.021.307 SH90.722.733 dólaresMaior em 52.679 Trimestre anterior: 968.628Abrir documento 0000886982-26-000647 Protocolado em 16 de nov. de 2026 Contestar esta linha
Holocene Advisors, LP 1.006.656 SH89.421.252 dólaresMenor em 170.805 Trimestre anterior: 1.177.461Abrir documento 0001172661-26-005338 Protocolado em 16 de nov. de 2026 Contestar esta linha
Freestone Grove Partners LP 1.004.008 SH89.186.031 dólaresNão consta nos documentos lidos do trimestre anterior Abrir documento 0001172661-26-005424 Protocolado em 16 de nov. de 2026 Contestar esta linha
VICTORY CAPITAL MANAGEMENT INC 989.067 SH87.858.830 dólaresMenor em 161.658 Trimestre anterior: 1.150.725Abrir documento 0001040188-26-000051 Protocolado em 10 de nov. de 2026 Contestar esta linha
Amundi Informado em parte sob outro gestor986.059 SH87.591.620 dólaresMaior em 266.780 Trimestre anterior: 719.279Abrir documento 0001172661-26-004884 Protocolado em 6 de nov. de 2026 Contestar esta linha
DEUTSCHE BANK AG\ Informado em parte sob outro gestor954.049 SH84.748.173 dólaresMaior em 30.497 Trimestre anterior: 923.552Abrir documento 0000948046-26-000083 Protocolado em 6 de nov. de 2026 Contestar esta linha
RAYMOND JAMES FINANCIAL INC Informado em parte sob outro gestor890.416 SH79.095.668 dólaresMaior em 24.246 Trimestre anterior: 866.170Abrir documento 0000720005-26-000081 Protocolado em 12 de nov. de 2026 Contestar esta linha
Quantinno Capital Management LP 887.922 SH78.874.167 dólaresMaior em 165.783 Trimestre anterior: 722.139Abrir documento 0001759654-26-000011 Protocolado em 13 de nov. de 2026 Contestar esta linha
JPMORGAN CHASE CO Informado em parte sob outro gestor821.627 SH75.047.642 dólaresMaior em 5.713 Trimestre anterior: 815.914Abrir documento 0000019617-26-000404 Protocolado em 12 de nov. de 2026 Contestar esta linha
Sound Shore Management Inc /CT/ 785.385 SH69.765.750 dólaresMenor em 9.217 Trimestre anterior: 794.602Abrir documento 0001193125-26-451148 Protocolado em 6 de nov. de 2026 Contestar esta linha
Boston Partners Informado em parte sob outro gestor755.041 SH67.077.301 dólaresMaior em 45.839 Trimestre anterior: 709.202Abrir documento 0001386060-26-000054 Protocolado em 10 de nov. de 2026 Contestar esta linha
ExodusPoint Capital Management, LP 686.151 SH60.950.793 dólaresMaior em 505.267 Trimestre anterior: 180.884Abrir documento 0001736225-26-000013 Protocolado em 16 de nov. de 2026 Contestar esta linha
THOMPSON SIEGEL WALMSLEY LLC Informado em parte sob outro gestor664.273 SH59.007 dólaresMaior em 30.985 Trimestre anterior: 633.288Abrir documento 0001008322-26-000012 Protocolado em 5 de nov. de 2026 Contestar esta linha
Barrenjoey Investment Management Ltd 610.651 SH54.244.128 dólaresMaior em 40.242 Trimestre anterior: 570.409Abrir documento 0001536105-26-000015 Protocolado em 16 de nov. de 2026 Contestar esta linha
Alberta Investment Management Corp 550.000 SH48.856.500 dólaresMaior em 252.106 Trimestre anterior: 297.894Abrir documento 0001123292-26-001506 Protocolado em 9 de nov. de 2026 Contestar esta linha
FIRST TRUST ADVISORS LP 544.038 SH48.326.911 dólaresMaior em 148.154 Trimestre anterior: 395.884Abrir documento 0001445546-26-008622 Protocolado em 12 de nov. de 2026 Contestar esta linha
Point72 Asset Management, L.P. 538.249 SH47.812.659 dólaresMenor em 341.602 Trimestre anterior: 879.851Abrir documento 0000919574-26-008126 Protocolado em 16 de nov. de 2026 Contestar esta linha
Swiss National Bank 529.200 SH47.008.836 dólaresMenor em 16.800 Trimestre anterior: 546.000Abrir documento 0001582202-26-000008 Protocolado em 12 de nov. de 2026 Contestar esta linha
Mitsubishi UFJ Asset Management Co., Ltd. Informado em parte sob outro gestor508.507 SH45.170.677 dólaresMaior em 26.452 Trimestre anterior: 482.055Abrir documento 0001193125-26-447983 Protocolado em 5 de nov. de 2026 Contestar esta linha
Boston Trust Walden Corp Informado em parte sob outro gestor499.389 SH44.360.725 dólaresMenor em 18.724 Trimestre anterior: 518.113Abrir documento 0001534866-26-000010 Protocolado em 30 de out. de 2026 Contestar esta linha
Gestores do trimestre anterior sem documento lido para o mais recente

Podem simplesmente ainda não ter entregue: a ausência nos documentos lidos do trimestre mais recente não significa posição vendida.

  • NORGES BANK 1.587.431 SH
  • Sixth Street Partners Management Company, L.P. 1.377.103 SH
  • Defilade Capital Management, L.P. 317.426 SH
  • CapitalatWork S.A. 297.000 SH
  • Parkman Healthcare Partners LLC 232.557 SH
  • SG Americas Securities, LLC 217.818 SH
  • ST GERMAIN D J CO INC 182.059 SH
  • Sio Capital Management, LLC 131.445 SH
  • Tredje AP-fonden 117.984 SH
  • NEW YORK STATE COMMON RETIREMENT FUND 113.475 SH
  • Longaeva Partners L.P. 98.054 SH
  • TUDOR INVESTMENT CORP ET AL 71.996 SH
  • Blue Sparrow, LLC /DE 70.500 SH
  • CAPITAL INTERNATIONAL SARL 42.034 SH
  • Walleye Trading LLC 34.700 SH
  • Aquatic Capital Management LLC 32.655 SH
  • EVERETT HARRIS CO /CA/ 29.647 SH
  • Walleye Trading LLC 28.500 SH
  • Jupiter Topco LLC 25.021 SH
  • CAPITAL INTERNATIONAL LTD /CA/ 24.782 SH
  • Jupiter Research Capital (Asia) Ltd 23.205 SH
  • D. E. Shaw Co., Inc. 22.400 SH
  • Summit Trail Advisors, LLC 21.558 SH
  • iA Global Asset Management Inc. 16.289 SH
  • Pacer Advisors, Inc. 14.682 SH
  • United Bank 14.621 SH
  • JOHNSON INVESTMENT COUNSEL INC 13.288 SH
  • Kentucky Retirement Systems 12.501 SH
  • CITIZENS NORTHERN CORP 12.277 SH
  • Quantitative Investment Management, LLC 11.712 SH
  • NewEdge Wealth, LLC 11.326 SH
  • Jain Global LLC 9.073 SH
  • Caprock Group, LLC 8.982 SH
  • Polymer Capital Management (US) LLC 6.867 SH
  • Aptus Capital Advisors, LLC 6.384 SH
  • Laurion Capital Management LP 5.540 SH
  • Kentucky Retirement Systems Insurance Trust Fund 5.188 SH
  • Total Clarity Wealth Management, Inc. 5.173 SH
  • Point72 Asset Management, L.P. 5.100 SH
  • Wahed Invest LLC 4.985 SH
  • CAPITAL GROUP INVESTMENT MANAGEMENT PTE. LTD. 4.777 SH
  • SummitTX Capital, L.P. 4.730 SH
  • HM PAYSON CO 4.669 SH
  • KEYNOTE FINANCIAL SERVICES LLC 4.652 SH
  • NICOLET BANKSHARES INC 4.467 SH
  • Premier Path Wealth Partners, LLC 4.297 SH
  • Meeder Advisory Services, Inc. 4.277 SH
  • Sovereign's Capital Management, LLC 4.197 SH
  • Boltwood Capital Management 3.760 SH
  • CIM INVESTMENT MANAGEMENT INC 3.719 SH
  • O Formulário 13F cobre apenas posições compradas em valores da Seção 13(f): nem posições vendidas nem valores fora dessa lista.
  • Um gestor que ainda não entregou o trimestre mais recente está ausente, não em zero; os documentos vencem até 45 dias após o fim do trimestre.
  • Uma diferença é a que existe entre dois retratos de fim de trimestre, não uma transação.
  • Uma posição informada sob outro gestor pode aparecer também no documento desse gestor; as linhas não se somam.
  • Posições que a lista de valores não consegue ligar a esta empresa, ou liga de forma ambígua, não são exibidas.

Detentores de 5 % (Schedules 13D e 13G)

Aqui são lidos os schedules entregues no formato estruturado da SEC (desde o fim de 2024). Os anteriores são texto livre e não são lidos.

Detentores de 5 %, evento mais recente primeiro, conforme entregue
DetentorPercentual da classeAções detidasData do eventoFormulárioFonte
Dodge Cox Common Stock12.524.124.73506/30/2026 Protocolado em 13 de ago. de 2026SCHEDULE 13G/AEmenda 5Abrir documento 0001193125-26-349494 Contestar esta linha
Capital International Investors Common Stock6.412.438.366,0006/30/2026 Protocolado em 12 de ago. de 2026SCHEDULE 13GAbrir documento 0001562230-26-000118 Contestar esta linha
T. Rowe Price Associates, Inc. COMMON STOCK4.17.997.80603/31/2026 Protocolado em 15 de mai. de 2026SCHEDULE 13G/AEmenda 1Abrir documento 0000080255-26-000400 Contestar esta linha
Vanguard Capital Management Common Stock7.5414.767.52703/31/2026 Protocolado em 30 de abr. de 2026SCHEDULE 13GAbrir documento 0002100119-26-001289 Contestar esta linha
The Vanguard Group Common Stock0003/13/2026 Protocolado em 27 de mar. de 2026SCHEDULE 13G/AEmenda 9Abrir documento 0000102909-26-002651 Contestar esta linha
HARRIS ASSOCIATES L P Common Stock, $0.01 par value6.212.264.703,0012/31/2025 Protocolado em 17 de fev. de 2026SCHEDULE 13GAbrir documento 0000813917-26-000021 Contestar esta linha
Harris Associates, Inc. Common Stock, $0.01 par value6.212.264.703,0012/31/2025 Protocolado em 17 de fev. de 2026SCHEDULE 13GAbrir documento 0000813917-26-000021 Contestar esta linha
Dodge Cox Common Stock11.222.097.46306/30/2025 Protocolado em 13 de ago. de 2025SCHEDULE 13G/AEmenda 4Abrir documento 0000950170-25-108132 Contestar esta linha

O percentual é da classe indicada no documento, como declarado pelo detentor. Os membros de um grupo informam cada um as ações do grupo, por isso as linhas não se somam.

O que foi lido

2.212.651 documentos lidos, de 14 de jun. de 2004 a 16 de nov. de 2026: Formulários 3, 3/A, 4, 4/A, 5, 5/A.

Alguns anos podem estar incompletos enquanto o arquivo ainda é lido. Um ano com poucos documentos aqui não afirma que poucos foram entregues.

Documentos lidos, por ano de entrega
Ano de entregaDocumentos lidos
20151
2016204.322
2017202.494
2018202.048
2019193.638
2020144.184
2021224.474
2022130.393
2023199.811
2024209.823
2025235.520
2026260.165

Os documentos anteriores à exigência de XML pela SEC são listados, mas não extraídos.

Voltar para ZIMMER BIOMET HOLDINGS, INC.